Market Overview:
The global flumazenil market is expected to grow at a CAGR of 5.5% during the forecast period from 2018 to 2030. The growth in the market can be attributed to factors such as rising incidence of benzodiazepine overdose, increasing number of emergency department visits, and growing demand for reversal agents. Based on type, the global flumazenil market is segmented into 98% purity and above 98% purity segments. The 98% purity segment is expected to account for a larger share of the global flumazenil market in 2018. This can be attributed to its lower price point as compared with products that are available in the above 98% purity segment. However, products that are available in the above 98% purity segment are expected to witness higher growth during the forecast period owing to their superior quality and efficacy profiles. Based on application, the global flumazenil market is divided into 2 ml injection, 5 ml injection, and 10 ml injection segments.
Product Definition:
Flumazenil is a benzodiazepine receptor antagonist used to reverse the effects of benzodiazepines in overdose.
98% Purity:
98% Purity is a new generation benzodiazepine with an unique mechanism of action. It has been designed to overcome the limitations associated to traditional benzodiazepines such as short duration of action and low potency. 98% Purity is expected to be effective in the treatment of anxiety disorders for at least 6 months, which would be a first for Benzodiazepines.
Above 98% Purity:
98% Purity or more commonly known as Pure is a special grade of benzodiazepine. It's an ultra-purified form which has very low impurities (less than 0.1%) and it's exclusively used in the treatment of acute alcohol detoxification, severe withdrawal symptoms from opioids/opioids, and flumazenil administration for pre-anesthetic preparation in surgical & medical procedures.
Application Insights:
2 ml injection was the major application segment and accounted for a revenue share of 92.1% in 2017. The product is used to treat life-threatening conditions such as respiratory depression and severe benzodiazepine toxicity. Flumazenil 2 ml injection is indicated for emergency treatment of benzodiazepine overdose, when conventional treatments have failed or are not feasible due to the risk of complications associated with an overdose of benzodiazepines (respiratory depression).
The 5 ml & 10ml injections segments are expected to witness significant growth over the forecast period owing to increasing use in treating patients who have taken multiple drugs, including alcohol and other sedatives/tranquilizers, opioids, antidepressants as well as antipsychotics.
Regional Analysis:
North America accounted for the largest share of global market in 2017. The presence of a large number of manufacturers coupled with high purity standards is expected to drive regional growth over the forecast period. Increasing cases of benzodiazepine dependence and anxiety disorders are also driving product demand in North America.
Asia Pacific is anticipated to witness lucrative growth over the forecast period owing to increasing investments by leading players, such as Teva Pharmaceuticals USA, Inc.; Mylan N.V.; Pfizer Inc.; and Merck & Co., Inc., among others for expanding their distribution networks and manufacturing facilities in this region.
Growth Factors:
- Increasing incidence of sleep disorders and its subsequent complications is expected to drive the demand for flumazenil over the forecast period.
- Growing geriatric population is also anticipated to fuel market growth as this population is more susceptible to developing sleep-related problems.
- Rising awareness about the benefits of flumazenil therapy is projected to propel market growth in coming years.
- Technological advancements in drug delivery systems are likely to provide new opportunities for market players over the forecast period
Scope Of The Report
Report Attributes
Report Details
Report Title
Flumazenil Market Research Report
By Type
98% Purity, Above 98% Purity
By Application
2 ml Injection, 5 ml Injection, 10 ml Injection
By Companies
ScinoPharm Taiwan, Midas Pharma, Hunan Warrant Chiral Pharmaceutical, Fuan Pharmaceutical, Hubei Haosun Pharmaceutical, Jiangsu Nhwa Pharmaceutical
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
195
Number of Tables & Figures
137
Customization Available
Yes, the report can be customized as per your need.
Global Flumazenil Market Report Segments:
The global Flumazenil market is segmented on the basis of:
Types
98% Purity, Above 98% Purity
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
2 ml Injection, 5 ml Injection, 10 ml Injection
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- ScinoPharm Taiwan
- Midas Pharma
- Hunan Warrant Chiral Pharmaceutical
- Fuan Pharmaceutical
- Hubei Haosun Pharmaceutical
- Jiangsu Nhwa Pharmaceutical
Highlights of The Flumazenil Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- 98% Purity
- Above 98% Purity
- By Application:
- 2 ml Injection
- 5 ml Injection
- 10 ml Injection
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Flumazenil Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Flumazenil is a benzodiazepine receptor antagonist. It is used to treat an overdose of benzodiazepines, including alcohol and prescription drugs. Flumazenil can also be used to reverse the effects of drowsiness caused by other medications.
Some of the key players operating in the flumazenil market are ScinoPharm Taiwan, Midas Pharma, Hunan Warrant Chiral Pharmaceutical, Fuan Pharmaceutical, Hubei Haosun Pharmaceutical, Jiangsu Nhwa Pharmaceutical.
The flumazenil market is expected to grow at a compound annual growth rate of 5.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Flumazenil Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Flumazenil Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Flumazenil Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Flumazenil Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Flumazenil Market Size & Forecast, 2020-2028
4.5.1 Flumazenil Market Size and Y-o-Y Growth
4.5.2 Flumazenil Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 98% Purity
5.2.2 Above 98% Purity
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 2 ml Injection
6.2.2 5 ml Injection
6.2.3 10 ml Injection
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Flumazenil Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Flumazenil Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 98% Purity
9.6.2 Above 98% Purity
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 2 ml Injection
9.10.2 5 ml Injection
9.10.3 10 ml Injection
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 98% Purity
10.6.2 Above 98% Purity
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 2 ml Injection
10.10.2 5 ml Injection
10.10.3 10 ml Injection
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 98% Purity
11.6.2 Above 98% Purity
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 2 ml Injection
11.10.2 5 ml Injection
11.10.3 10 ml Injection
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 98% Purity
12.6.2 Above 98% Purity
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 2 ml Injection
12.10.2 5 ml Injection
12.10.3 10 ml Injection
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 98% Purity
13.6.2 Above 98% Purity
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 2 ml Injection
13.10.2 5 ml Injection
13.10.3 10 ml Injection
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Flumazenil Market: Competitive Dashboard
14.2 Global Flumazenil Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 ScinoPharm Taiwan
14.3.2 Midas Pharma
14.3.3 Hunan Warrant Chiral Pharmaceutical
14.3.4 Fuan Pharmaceutical
14.3.5 Hubei Haosun Pharmaceutical
14.3.6 Jiangsu Nhwa Pharmaceutical
